Data Center Market to Grow at a CAGR of 11.51% from 2025 to 2032 | SkyQuest Technology Consulting
WESTFORD, Mass., July 28, 2025 /PRNewswire/ — SkyQuest Technology Consulting published a report, titled, Data Center Market– Global Opportunity Analysis and Industry Forecast, 2025-2032″, valued at USD 505.8 Billion in 2024. With a projected CAGR of 11.51% from 2025 to 2032, the market is expected to reach USD 1,189.5 Billion by the end of 2032. Significant rise in […]
Solid-State Battery Market worth $1.77 billion by 2031 – Exclusive Report by MarketsandMarkets™
DELRAY BEACH, Fla., July 28, 2025 /PRNewswire/ — The global solid-state battery market is projected to grow from USD 0.26 billion in 2025 to USD 1.77 billion by 2031, at a CAGR of 37.5% according to a new report by MarketsandMarkets™. Demand for electric vehicles, renewable energy storage, and portable electronics fuels interest in solid-state […]
Yotta 2025 Reveals Powerhouse Main Stage Lineup
Digital infrastructure’s most influential voices take the stage at Yotta 2025. With ticket prices increasing on August 2, now’s the time to secure your spot at the industry’s can’t-miss event. NEW YORK, July 28, 2025 /PRNewswire/ — The stage is set. Yotta 2025, the must-attend event for digital infrastructure leaders, has just announced its biggest, boldest […]
SHEIN X TEAMS UP WITH HOUSE OF ONE FOR A CHIC, ACCESSIBLE CAPSULE COLLECTION
The Collection Features Polished Staples, Soft Tailoring, and Affordable Indulgence for Every Moment on Your Calendar LOS ANGELES, July 28, 2025 /PRNewswire/ — SHEIN X, the collaboration platform under global fashion and lifestyle online retailer SHEIN, introduces its latest designer drop: a limited-edition capsule with modern womenswear label House of One. Designed for women who dress […]
SF Hep B Free – Bay Area Evolves into ‘Hep B Free’ to Unite and Empower Hepatitis B Advocates Across the U.S. and Beyond
SAN FRANCISCO, July 28, 2025 /PRNewswire/ — On World Hepatitis Day, SF Hep B Free – Bay Area, a nationally recognized grassroots leader in hepatitis B care and liver cancer prevention, is expanding its mission and reach under a new name: Hep B Free. This transformation marks a bold step toward uniting and empowering hepatitis […]
Gift of Life in Collaboration with Labcorp and DOUBLEMINT®, Launch Hero Gum to Expand Marrow Donor Registry
New initiative makes joining the marrow registry as easy as chewing gum Awareness drive kicks off at the Mets game on Aug. 1 NEW YORK, July 28, 2025 /PRNewswire/ — Signing up for the stem cell registry just got a whole lot easier — and tastier — thanks to a bold new initiative from Gift of Life Marrow Registry. In collaboration […]
AXA XL Appoints Sylvain Bouteillé as Chief Underwriting Officer, Specialty, Americas
NEW YORK , July 28, 2025 /PRNewswire/ — AXA XL is pleased to announce the appointment of Sylvain Bouteillé as Chief Underwriting Officer for Specialty Americas. In this key leadership role, Mr. Bouteillé will oversee the development and execution of AXA XL’s regional strategy for its Specialty insurance division which includes Aviation, Ocean Marine, Political Risk, […]
Sapphire LLC to Launch ReturnMail.ai to Automate Return Mail Processing for High-Volume Organizations
WASHINGTON, July 28, 2025 /PRNewswire/ — Sapphire LLC, founded by entrepreneurs Almustafa “Almo” El Hillo and Deron Cooper, is preparing to launch ReturnMail.ai, a software platform that uses artificial intelligence to automate return mail processing — a longstanding manual workflow in both government and enterprise operations. Continue Reading Launching in August 2025, ReturnMail.ai is conducting demos […]
Banorte, led by Carlos Hank-González, is recognized as the Best Bank for SMEs in Mexico by Euromoney
The specialized publication recognized Banorte for its key role in financing and supporting Mexican small and medium-sized enterprises. In the SME segment during 2024, Banorte positioned itself as one of the main players in Mexico with a 15% share in loans and 14% in deposits. MEXICO CITY, July 28, 2025 /PRNewswire/ — Banorte was distinguished […]
Avidity Biosciences Announces Completion of Enrollment for HARBOR™, the First Global Phase 3 Trial of Delpacibart Etedesiran (del-desiran) for Treatment of DM1 and Provides Guidance on Regulatory Submission
— Topline data readout from HARBOR study anticipated in Q2 2026 —— Marketing application submissions for del-desiran including in U.S., EU and Japan anticipated to start in H2 2026; on track to potentially be the first globally approved drug for DM1–— On track to share updates from ongoing MARINA-OLE™ trial of del-desiran including long-term 4 mg/kg […]